|
APEX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.344700E-03 |
| Normal-vs-Stage3 |
5.56099999999837E-05 |
| Normal-vs-Stage4 |
5.185900E-04 |
| Stage1-vs-Stage2 |
7.86799999999976E-05 |
| Stage1-vs-Stage3 |
3.7505999999965E-05 |
| Stage1-vs-Stage4 |
1.607210E-04 |
| Stage2-vs-Stage3 |
4.826000E-01 |
| Stage2-vs-Stage4 |
5.480000E-01 |
| Stage3-vs-Stage4 |
9.196000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.52979999954195E-07 |
| Normal-vs-Asian |
2.538100E-02 |
| Caucasian-vs-AfricanAmerican |
1.651790E-01 |
| Caucasian-vs-Asian |
3.704200E-01 |
| AfricanAmerican-vs-Asian |
7.587400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.01252339845814E-13 |
| Male-vs-Female |
8.120000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.643690E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62569957495862E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62714286489063E-12 |
| Normal-vs-Age(81-100Yrs) |
1.404170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.519800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.019200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.167430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.296800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.387050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.954610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.8440000000286E-06 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.14609988166592E-10 |
| Normal-vs-Grade 4 |
1.102770E-01 |
| Grade 1-vs-Grade 2 |
6.618500E-02 |
| Grade 1-vs-Grade 3 |
7.296400E-03 |
| Grade 1-vs-Grade 4 |
2.4390999999957E-05 |
| Grade 2-vs-Grade 3 |
3.100700E-03 |
| Grade 2-vs-Grade 4 |
1.64429999949256E-07 |
| Grade 3-vs-Grade 4 |
6.658100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.016350E-04 |
| ccA subtype-vs-ccB subtype |
1.47890000246065E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04374320087209E-12 |
| Normal-vs-N1 |
2.090800E-01 |
| N0-vs-N1 |
1.382030E-04 |
|
|
